fda tirzepatide osa Approves (Zepbound) as the First Medication for Obstructive Sleep Apnea Huge news: FDA has approved

Some GLP-1 users live with nausea, constipation, and lethargy

Thats why we work hard to support our members achieve a healthy weight by improving access to nutritious food, physical activity programs, and quality clinical care when needed, David Merritt, senior vice president of external affairs for the Blue Cross Blue Shield Association, said in a statement

These studies may investigate retatrutides effects on other metabolic health factors, including cholesterol or heart risk

But they add to a growing body of evidence suggesting GLP-1 receptor agonists may have real mental health benefits worth studying further

According to US obesity treatment guidelines, continuation of therapy should be reassessed if a patient has not lost at least 5% of baseline weight after approximately 3 months on the maintenance dose

Interestingly, while the weights of four different skeletal muscles were measured, no significant changes were observed, although a trend toward decreased muscle mass was noted